FindTrial
Sign In

Pharmacogenetic testing

OTHER17 trials

Sponsors

Genelex Corporation, Avera McKennan Hospital & University Health Center, Duke University, University of Arizona, Cairo University

Conditions

Acute PainAdverse Drug EventsAdverse Drug Reaction (ADR)Adverse Drug ReactionsCYP2D6 PolymorphismCancer CachexiaCancer PainChronic Pain

Phase 3

Pharmacogenetics in Primary Care Psychotropics
NCT03232502
University of ArizonaDepression, Generalized Anxiety Disorder, Obsessive-Compulsive Disorder
Start: 2017-08-15End: 2018-12-31Target: 130Updated: 2017-07-28

Unknown Phase

Pharmacogenetic Testing Among Home Health Patients
CompletedNCT02378220
Genelex CorporationAdverse Drug Events, Adverse Drug Reactions, Cytochrome P450 CYP2C19 Enzyme Deficiency +10
Start: 2015-03-31End: 2016-03-31Updated: 2019-09-20
Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
CompletedNCT02428660
Genelex CorporationCYP2D6 Polymorphism, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency +6
Start: 2015-02-28End: 2017-02-28Updated: 2017-02-23
Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis
CompletedNCT02443584
Avera McKennan Hospital & University Health CenterMajor Depressive Disorder
Start: 2015-02-01End: 2017-04-01Updated: 2017-05-03
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
CompletedNCT02474680
Avera McKennan Hospital & University Health CenterMajor Depressive Disorder 1
Start: 2015-11-01End: 2017-01-01Updated: 2017-05-03
Pharmacogenetic Testing in an Outpatient Population of Patients With Depression
CompletedNCT02497027
Avera McKennan Hospital & University Health CenterDepression
Start: 2015-02-28End: 2017-04-01Updated: 2017-05-03
Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting
CompletedNCT02937545
Duke UniversityPharmacogenetics
Start: 2017-02-22End: 2019-09-10Updated: 2021-06-03
Effect of Gene Polymorphisms on the Pathogenesis of Cancer Cachexia
NCT04131478
Cairo UniversityCancer Cachexia
Start: 2019-06-20End: 2021-01-01Target: 150Updated: 2019-11-12
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (DCRI Coordinating Center)
CompletedNCT04445792
Duke UniversityAcute Pain, Chronic Pain, Depression
Start: 2021-02-24End: 2024-05-10Updated: 2026-03-25
Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care
Active, not recruitingNCT04685304
Medstar Health Research InstituteChronic Pain
Start: 2020-12-02End: 2024-04-11Target: 315Updated: 2024-03-26
Pharmacogenetic Supported Prescribing in Kids
RecruitingNCT04797364
University of CalgaryMental Health Impairment
Start: 2021-01-18End: 2025-07-01Target: 6000Updated: 2024-05-09
Pharmacogenetic-guided Choice of Post-surgery Analgesics
CompletedNCT05548660
University of PennsylvaniaAcute Pain, Post Operative Pain
Start: 2022-10-13End: 2025-02-01Updated: 2026-04-01
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
RecruitingNCT05830279
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sCancer Pain, Depression, Reactive, Nausea With Vomiting Chemotherapy-Induced
Start: 2023-05-01End: 2026-04-30Target: 600Updated: 2025-07-09
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Chronic Pain Trial)
CompletedNCT05966142
Duke UniversityChronic Pain
Start: 2021-02-24End: 2024-05-10Updated: 2025-05-28
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)
CompletedNCT05966129
Duke UniversityAcute Pain
Start: 2021-03-10End: 2024-03-25Updated: 2026-03-19
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)
CompletedNCT05966155
Duke UniversityDepression
Start: 2021-08-10End: 2024-04-27Updated: 2025-06-29
Pharmacogenomics-Supported Psychotropic Prescribing Trial
RecruitingNCT06929533
University of ManitobaAdverse Drug Reaction (ADR), Effectiveness, Mental Disorder +1
Start: 2025-07-01End: 2030-12-31Target: 200Updated: 2025-09-08

Related Papers

CYP2D6-Guided Opioid Management and Postoperative Pain Control
JAMA Network Open2026-02-20
Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine
Journal of Child and Adolescent Psychopharmacology2024-02-016 citations
Impact of TNF-α Gene Polymorphisms on Pancreatic and Non-Small Cell Lung Cancer-Induced Cachexia in Adult Egyptian Patients: A Focus on Pathogenic Trajectories
Frontiers in Oncology2021-11-1815 citations
Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients
Journal of Managed Care & Specialty Pharmacy2018-11-2749 citations
Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
PLoS ONE2017-02-02161 citations